Delivery Order SPE2DB22D1103-SPE2DB25FH3D4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,117.08 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $74.3K delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with completion scheduled for September 19, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $126,226.42 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-unit packages). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was competitively awarded without a set-aside designation. The award was issued on September 22, 2025, to the vendor's corporate office located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $24,313.46 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30s. This is a firm fixed price delivery order with an ultimate completion date of September 24, 2025, issued on September 23, 2025. The award carries no set-aside designation and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order serves as a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,361.18 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency awarded a delivery order valued at $6,394.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price terms with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $36,293.07. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3D4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,376.16 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 24, 2025, represents a non-competitive award and constitutes a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to fulfill competitive federal procurement requirements positions it as a critical vendor in the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/24/25 |